Skip to content
AlternativeMed

Electrical-Stimulation Risks

What is known about the risks of electrical brain stimulation outside clinics, including skin injury, mood effects, unknowns for vulnerable groups, and why published safety findings do not cover home use.

Content last updated . This page has not been medically reviewed.

Safety first

This page gives no settings, no how-to and no advice to try stimulation at home. It describes risks so you can judge claims.

Get urgent help if someone has a seizure, collapses, has a severe burn, or is in a mental health crisis. In the US, call 911, or call or text 988 (the Suicide & Crisis Lifeline) for emotional crisis.

If you have epilepsy, a head injury, a brain implant, a mental health condition such as bipolar disorder, or are pregnant, talk with the clinician who treats you before considering any head stimulation. Evidence for children and adolescents is thin (see the FAQ). The reasons are below.

What this covers

Transcranial electrical stimulation passes weak electrical current through the scalp. Types include tDCS (direct current), tACS (alternating current) and cranial electrotherapy stimulation (CES). Basics are in tDCS and tACS: Educational Overview and Risks. Clinical neuromodulation is covered in Neuromodulation for Depression: Evidence by Technique.

Evidence labels used: promising but limited, insufficient evidence, mixed, marketing claim, evidence of harm. See How We Label Evidence in Biohacking.

What research reports as common effects

Reviews of laboratory and clinical studies describe mostly mild effects: headache, fatigue, and prickling or burning sensations under the electrodes. Skin burns have been reported, linked to poor electrode-to-skin contact. [1] For CES, FDA's 2016 proposed order listed skin irritation, headaches and dizziness, and said device malfunction could cause electrical shock or burns. [2]

Rare but serious: mood effects

A guideline paper counted 11 documented cases of mania or hypomania after stimulation in people with depression, while noting that cause is hard to prove because cases are few. [1] Anyone with bipolar disorder or a history of mania should treat this as a reason for clinician supervision.

Thinking effects can cut both ways

In one experiment, healthy adults learning a new number system had better learning but worse automatic recall of the material with stimulation to one brain area, and the reverse with another area. The authors concluded that enhancement of one cognitive function "can occur at the expense of other cognitive functions". [3] This was a small laboratory study; it shows a possible trade-off, not a general rule.

Safety findings come from supervised studies

Published safety reviews are built from supervised sessions in research and clinical settings. One review defines safety as the absence of evidence of a serious adverse effect in those trials and flags children, older adults, people with mood disorders, epilepsy, stroke or implants, and home users as groups needing special consideration. [4] A guideline paper says its safety conclusions apply to specific conventional low-intensity protocols, and that animal and modelling work suggests injury could occur at much higher exposure. [1] Those conclusions do not tell you that a consumer product, used unsupervised with different electrodes and settings, is equally safe.

Home use is a known weak point. A randomized trial of home tDCS for depression was ended early after skin lesions accumulated; only 11 patients had been enrolled, and the authors concluded safety monitoring was not enough to detect or prevent the problems in time. [5]

Benefit claims are weaker than the marketing

Insufficient evidence is the fair label for most consumer claims. A systematic review of CES for pain, depression, anxiety and insomnia found the evidence insufficient for clinically important effects on most conditions, with low-strength evidence of modest benefit for anxiety and depression, and all trials at high risk of bias. [6] Low-strength evidence suggested no serious side effects in those trials. [6]

Why regulation does not settle it

In the US, whether a stimulation device is regulated depends on its intended use. [7] FDA's general wellness guidance lists a neurostimulation product claiming to improve memory as an example of a product that is not low risk. [8] See Clinical Devices vs Wellness Gadgets and Unregulated Neurotechnology.

How to judge a stimulation claim

  • Ask for human trials of the exact device, not of other equipment.
  • Look for who ran the studies and who paid.
  • Be cautious when "natural", "gentle" or "low-level" is offered as proof of safety.
  • Treat brain-performance claims as marketing until trials show real-world benefit.

Frequently asked questions

Is electrical brain stimulation safe at home?

Safety findings come from supervised studies. Reviews flag home users as a group needing special consideration, and one home depression trial stopped early because of skin lesions. [4][5]

What side effects have been reported?

Headache, fatigue, tingling or burning under the electrodes, and occasionally skin burns. [1]

Can stimulation trigger mania?

Eleven cases of mania or hypomania in people with depression have been documented, although cause is hard to prove. [1]

Is it safe for children?

A review of pediatric studies called the evidence "sporadic and scarce". [9] See Neurological and Psychiatric Considerations for Neurotechnology.

Does stimulation improve memory in healthy people?

This page found no source showing reliable real-world benefit. One experiment found enhancement of one skill came with a cost to another. [3]

References
  1. Antal A et al. Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol 2017. PubMed abstract. Read 2026-10-22.
  2. FDA. Cranial electrotherapy stimulator devices: proposed order (Federal Register, 22 January 2016). A proposed order, not the final order. Read 2026-10-22.
  3. Iuculano T, Cohen Kadosh R. The mental cost of cognitive enhancement. J Neurosci 2013. PubMed abstract. Read 2026-10-22.
  4. Bikson M et al. Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. Brain Stimul 2016. PubMed abstract. Read 2026-10-22.
  5. Kumpf U et al. tDCS at home for depressive disorders: an updated systematic review and lessons learned from a prematurely terminated randomized controlled pilot study. Eur Arch Psychiatry Clin Neurosci 2023. PubMed abstract. Read 2026-10-22.
  6. Shekelle PG et al. Benefits and Harms of Cranial Electrical Stimulation for Chronic Painful Conditions, Depression, Anxiety, and Insomnia: A Systematic Review. Ann Intern Med 2018. PubMed abstract. Read 2026-10-22.
  7. Wexler A. A pragmatic analysis of the regulation of consumer transcranial direct current stimulation (TDCS) devices in the United States. J Law Biosci 2015. PubMed abstract. Read 2026-10-22.
  8. FDA. General Wellness: Policy for Low Risk Devices, guidance for industry and FDA staff, January 2026. Full guidance PDF read. Read 2026-10-22.
  9. Buchanan DM et al. Systematic Review on the Safety and Tolerability of Transcranial Direct Current Stimulation in Children and Adolescents. Brain Sci 2021. PubMed abstract. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.